MIST
Price
$1.94
Change
-$0.08 (-3.98%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
170.84M
50 days until earnings call
PCVX
Price
$33.14
Change
-$0.33 (-0.99%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
4.35B
48 days until earnings call
Interact to see
Advertisement

MIST vs PCVX

Header iconMIST vs PCVX Comparison
Open Charts MIST vs PCVXBanner chart's image
Milestone Pharmaceuticals
Price$1.94
Change-$0.08 (-3.98%)
Volume$5.34K
Capitalization170.84M
Vaxcyte
Price$33.14
Change-$0.33 (-0.99%)
Volume$32.59K
Capitalization4.35B
MIST vs PCVX Comparison Chart in %
Loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIST vs. PCVX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIST is a Hold and PCVX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (MIST: $2.01 vs. PCVX: $33.47)
Brand notoriety: MIST and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIST: 71% vs. PCVX: 137%
Market capitalization -- MIST: $170.84M vs. PCVX: $4.35B
MIST [@Biotechnology] is valued at $170.84M. PCVX’s [@Biotechnology] market capitalization is $4.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.23B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIST’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • MIST’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than MIST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIST’s TA Score shows that 5 TA indicator(s) are bullish while PCVX’s TA Score has 6 bullish TA indicator(s).

  • MIST’s TA Score: 5 bullish, 5 bearish.
  • PCVX’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than MIST.

Price Growth

MIST (@Biotechnology) experienced а +2.03% price change this week, while PCVX (@Biotechnology) price change was +7.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

MIST is expected to report earnings on Nov 12, 2025.

PCVX is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.35B) has a higher market cap than MIST($171M). MIST YTD gains are higher at: -14.831 vs. PCVX (-59.113). MIST has higher annual earnings (EBITDA): -51.72M vs. PCVX (-584.35M). PCVX has more cash in the bank: 1.66B vs. MIST (43.4M). MIST has less debt than PCVX: MIST (56.4M) vs PCVX (85.8M). MIST (0) and PCVX (0) have equivalent revenues.
MISTPCVXMIST / PCVX
Capitalization171M4.35B4%
EBITDA-51.72M-584.35M9%
Gain YTD-14.831-59.11325%
P/E RatioN/AN/A-
Revenue00-
Total Cash43.4M1.66B3%
Total Debt56.4M85.8M66%
FUNDAMENTALS RATINGS
MIST: Fundamental Ratings
MIST
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MISTPCVX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 19 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
COMZX31.790.30
+0.95%
DWS Digital Horizons Inst
FMMMX47.630.09
+0.19%
American Funds AMCAP 529-F-2
GSVTX16.90N/A
N/A
Goldman Sachs Large Cap Value Inv
BOSVX19.19-0.01
-0.05%
Bridgeway Omni Small-Cap Value N
LMNVX132.94-0.15
-0.11%
ClearBridge Value I

MIST and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIST has been loosely correlated with PCVX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MIST jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+4.69%
PCVX - MIST
52%
Loosely correlated
+5.42%
EQ - MIST
41%
Loosely correlated
-0.68%
KRYS - MIST
36%
Loosely correlated
+1.13%
TSHA - MIST
32%
Poorly correlated
+1.41%
JBPHF - MIST
31%
Poorly correlated
N/A
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with MIST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+5.42%
MIST - PCVX
52%
Loosely correlated
+4.69%
KYMR - PCVX
47%
Loosely correlated
+3.83%
SYRE - PCVX
46%
Loosely correlated
+2.76%
BEAM - PCVX
46%
Loosely correlated
+0.37%
TSHA - PCVX
46%
Loosely correlated
+1.41%
More